Wilmington, Delaware, United States, Transparency Market Research Inc. – Atherosclerosis is the thickening, hardening, and loss of elasticity of the walls of the arteries.
Wilmington, Delaware, United States, Transparency Market Research Inc. – Atherosclerosis is the thickening, hardening, and loss of elasticity of the walls of the arteries. It is also known as arteriosclerosis. Atherosclerosis results in plaque formation inside the arteries. Arteries are blood vessels that carry blood from the heart to other parts of the body. Arteries are lined by a thin layer of cells known as endothelium.
Read Report Overview - https://www.transparencymarketresearch.com/atherosclerosis-therapeutics-market.html
Atherosclerosis begins with the damage of endothelium due to smoking, high cholesterol, and high blood pressure. That damage leads to the formation of plaque. Plaque is made of calcium, cholesterol, fat, and other substances found in the blood.
Accumulation of plaque causes hardening and narrowing of the arteries. Gradually, plaque grows in size and may partially or totally block blood flow and reduce blood flow to organs such as the heart and other parts of your body. This can lead to serious problems including stroke, heart attack, or even death.
Atherosclerosis can affect any artery in the body, including arteries in the legs, brain, heart, arms, pelvis, and legs, resulting in the development of different diseases based on which arteries are affected. Atherosclerosis plaques causes three main types of cardiovascular diseases: coronary artery disease, cerebrovascular disease, and peripheral artery disease.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=59790
Coronary heart disease (CHD) or coronary artery disease is a major cause of death and disability across the world. CHD is responsible for about one-third or more of total deaths in the population over age 35. It is estimated that one-third of middle-aged women and half of all middle-aged men in the U.S. develop some manifestation of coronary heart disease.
Key Drivers, Restraints, and Opportunities of Global Atherosclerosis Therapeutics Market
The global atherosclerosis therapeutics market is expected to expand, due to an increase in the geriatric population and rise in the incidence rate of heart attacks due to coronary heart disease or atherosclerosis. Additionally, availability of new treatment approaches (branded and generic) is a key factor driving the global atherosclerosis therapeutics market.
According to the Centers for Disease Control and Prevention (CDC), about 610, 000 people from the U.S. died due to heart diseases, which is nearly one in every four deaths. Among heart diseases, coronary artery disease is a highly common heart disease, causing about 370,000 deaths per year. These factors are estimated to boost the global atherosclerosis therapeutics market. However, dependence on symptom-based treatment in several cases and limited efficacy and side-effects of the drugs available in the market are expected to restrain the global atherosclerosis therapeutics market during the forecast period.
Request for ToC – https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=59790
North America to Capture Major Share of Global Atherosclerosis Therapeutics Market
In terms of region, the global atherosclerosis therapeutics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to dominate the global market during the forecast period due to the presence of major players, higher cases of cardiovascular diseases and atherosclerosis, and well-established healthcare infrastructure. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are key factors that are anticipated to boost the market.
The U.S. held a major share of the market in North America due to supportive healthcare policies, a high number of patients, and a developed healthcare market. About 647,000 people in the U.S. die from heart disease every year, i.e., 1 in every 4 deaths. Heart disease costs the U.S. around US$ 219 billion each year. According to statistics, an increase in patient pool and disposable income in this country propels the market of the region.
Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=59790
Key Players Operating in Global Atherosclerosis Therapeutics Market
The atherosclerosis drugs market is moderately competitive and includes major players. Major players operating in the global atherosclerosis therapeutics market are:
- Pfizer Inc.
- AstraZeneca
- Merck & Co., Inc.
- Sanofi US
- Amgen Inc.
- Novartis AG
- GlaxoSmithKline Plc
- Bayer AG
- Mylan N.V.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- Isis Pharmaceuticals, Inc.
- Anthera Pharmaceuticals
- Johnson and Johnson
- Cardium Therapeutics
- The Medicine Company
More Trending Reports by Transparency Market Research –
Structural Heart Devices Market: The global structural heart devices market is estimated to develop at a CAGR of 7.5% during the forecast period 2019 to 2027.
Stem Cells Market: The global stem cells market is expected to reach the value of US$ 25.68 Bn by the end of 2028.
Medical Imaging Equipment Market: The global medical imaging equipment market is expected to reach the value of US$ 50.3 Bn by the end of 2028.
Home Healthcare Market: The global home healthcare market is expected to reach the value of US$ 499.6 Bn by the end of 2028.
Triclabendazole Market: The global triclabendazole market is expected to reach the value of US$ 632.1 Mn by the end of 2031.
Anti-aging Market: The global anti-aging market is expected to surpass the value of US$ 284.8 Bn by the end of 2028.
Brucellosis Vaccine Market: The global brucellosis vaccine market is projected to grow at a CAGR of 4% during the forecast period.
Solitary Fibrous Tumor Treatment Market: The solitary fibrous tumor treatment market is projected to expand at a modest CAGR of 4.5% during the forecast period.
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com